ITIH2

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0004867 serine-type endopeptidase inhibitor activity	IEA GO_REF:0000120	REMOVE	Summary: This IEA annotation is based on InterPro domain mapping and UniProtKB keyword assignment. While ITIH2 is part of the inter-alpha-inhibitor complex, the actual serine protease inhibitor activity resides in the bikunin subunit, not in the ITIH2 heavy chain itself. Reason: ITIH2 (the heavy chain H2) does not possess intrinsic serine-type endopeptidase inhibitor activity. The inhibitory activity of the inter-alpha-inhibitor complex comes from the bikunin light chain, not from the heavy chains. As stated in PMID:2476436, "each protein contained a single, identical, trypsin-inhibitory chain of 30,000 Da" referring to bikunin, while "Inter-alpha-trypsin inhibitor contains noninhibitory heavy chains of 65,000 and 70,000 Da." ITIH2 is one of these noninhibitory heavy chains. The deep research confirms "ITIH2 acts as a serine-type endopeptidase inhibitor" is misleading - it's the bikunin component that has this activity. Supporting Evidence: PMID:2476436 Analysis of the proteins, the separated chains, and proteolytic derivatives thereof revealed that each protein contained a single, identical, trypsin-inhibitory chain of 30,000 Da. Inter-alpha-trypsin inhibitor contains noninhibitory heavy chains of 65,000 and 70,000 Da file:human/ITIH2/ITIH2-deep-research-falcon.md protease inhibition is primarily attributed to bikunin, while the best-characterized function of heavy chains (including ITIH2/HC2) is structural, namely covalent modification of HA in extracellular matrices
GO:0005576 extracellular region	IEA GO_REF:0000044	ACCEPT	Summary: This IEA annotation is based on UniProtKB subcellular location vocabulary mapping. ITIH2 is indeed a secreted protein found in plasma and extracellular fluids. However, this term is very broad and less informative than more specific cellular component annotations available. Reason: While this annotation is correct, it is quite general. ITIH2 is secreted into plasma and the extracellular space as confirmed by UniProt ("Secreted") and deep research showing it is a "secreted plasma protein found in the extracellular space." The annotation is supported by experimental evidence (PMID:14718574) which identified ITIH2 in the human plasma proteome. This term is acceptable as a broad localization statement, though more specific terms like "extracellular matrix" provide better functional context. Supporting Evidence: PMID:14718574 The human plasma proteome: a nonredundant list developed by combination of four separate sources
GO:0030212 hyaluronan metabolic process	IEA GO_REF:0000002	ACCEPT	Summary: This IEA annotation is based on InterPro domain mapping. ITIH2 plays a crucial role in hyaluronan biology through TSG-6-mediated transfer of heavy chains to hyaluronan, stabilizing the ECM and regulating hyaluronan localization and interactions. Reason: This annotation accurately captures a core function of ITIH2. The protein is directly involved in hyaluronan metabolic processes through its interactions with hyaluronan. PMID:20463016 demonstrates that "TSG-6/HC2 transfer HCs from bikunin proteins to HA" and shows "a dynamic shuffling of the HCs occur in vivo" between glycosaminoglycans including hyaluronan. The deep research confirms ITIH2 "binds and stabilizes hyaluronan in the ECM" and is "covalently linking to hyaluronan, mediated by TSG-6." UniProt states ITIH2 may act as "a binding protein between hyaluronan and other matrix protein...to regulate the localization, synthesis and degradation of hyaluronan." Supporting Evidence: PMID:20463016 The heavy chain (HC) subunits of the bikunin proteins are covalently attached to a single chondroitin sulfate (CS) chain originating from bikunin and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2 file:human/ITIH2/ITIH2-uniprot.txt May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan PMID:39149600 TSG-6 is essential for the interaction with HA because it facilitates two following ester exchange reactions: it binds HC1 or HC2 of IαI family covalently and then moves them to the HA fraction in this complex, where the heavy chain conjugates and releases free TSG-6
GO:0030414 peptidase inhibitor activity	IEA GO_REF:0000043	REMOVE	Summary: This IEA annotation is based on UniProtKB keyword mapping. Like GO:0004867, this annotation incorrectly attributes the protease inhibitor activity of the inter-alpha-inhibitor complex to the ITIH2 heavy chain, when it actually resides in the bikunin subunit. Reason: ITIH2 itself does not have peptidase inhibitor activity. This is the same fundamental issue as GO:0004867. The heavy chains (including ITIH2/HC2) are structural components that are linked to bikunin via chondroitin sulfate, but they do not possess enzymatic inhibitor activity. PMID:2476436 clearly identifies bikunin as "the trypsin-inhibitory chain" while describing ITIH2 and other heavy chains as "noninhibitory." The annotation conflates the complex's activity with ITIH2's individual molecular function. Supporting Evidence: PMID:2476436 Inter-alpha-trypsin inhibitor contains noninhibitory heavy chains of 65,000 and 70,000 Da file:human/ITIH2/ITIH2-deep-research-falcon.md This is not an enzyme in the classical "substrate → product" sense; rather, ITIH2 contributes a reactive heavy chain that becomes part of the HA polymer's covalent decoration
GO:0005515 protein binding	IPI PMID:16873769 TSG-6 potentiates the antitissue kallikrein activity of inte...	MODIFY	Summary: This IPI annotation is based on experimental evidence showing ITIH2 interaction with bikunin in the context of TSG-6-mediated complex formation. While technically correct, the generic "protein binding" term is uninformative and should be replaced with more specific molecular function terms. Reason: PMID:16873769 demonstrates that TSG-6 interacts with heavy chains from inter-alpha-inhibitor, stating "TSG-6 forms covalent complexes with heavy chains (HCs) from inter-alpha-inhibitor and pre-alpha-inhibitor and associates noncovalently with their common bikunin chain." While this confirms protein-protein interaction, the term "protein binding" is too vague per curation guidelines. ITIH2's role is better captured by more specific terms describing its function in hyaluronan binding and ECM organization rather than generic protein binding. Proposed replacements: hyaluronic acid binding Supporting Evidence: PMID:16873769 TSG-6 (the protein product of TNF-stimulated gene-6), an inflammation-associated protein, forms covalent complexes with heavy chains (HCs) from inter-alpha-inhibitor and pre-alpha-inhibitor and associates noncovalently with their common bikunin chain
GO:0005515 protein binding	IPI PMID:20463016 The TSG-6/HC2-mediated transfer is a dynamic process shuffli...	MODIFY	Summary: This IPI annotation is based on experimental evidence showing ITIH2 interaction with TSG-6 and involvement in the dynamic transfer of heavy chains between glycosaminoglycans. Like the previous protein binding annotation, this is too generic. Reason: PMID:20463016 demonstrates extensive protein-protein interactions in the context of TSG-6/HC2-mediated transfer, showing "TSG-6 and HC2 transfer HCs from bikunin proteins to HA in a reaction that involves two sequential transesterifications." While protein binding is occurring, this generic term does not capture the specific molecular function. The paper demonstrates hyaluronan binding activity and dynamic interactions with glycosaminoglycans, which are better represented by GO:0005540 (hyaluronic acid binding). Proposed replacements: hyaluronic acid binding Supporting Evidence: PMID:20463016 In concert, TSG-6 and HC2 transfer HCs from bikunin proteins to HA in a reaction that involves two sequential transesterifications
GO:0005540 hyaluronic acid binding	IDA PMID:20463016 The TSG-6/HC2-mediated transfer is a dynamic process shuffli...	ACCEPT	Summary: This IDA annotation is based on direct experimental evidence demonstrating ITIH2's ability to bind hyaluronan through TSG-6-mediated transfer reactions. This represents a core molecular function of ITIH2. Reason: This annotation accurately captures a core molecular function of ITIH2. PMID:20463016 directly demonstrates that "heavy chain (HC) subunits of the bikunin proteins...can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2" and shows "HC·HA complex" formation. The paper demonstrates reversible binding, showing "HCs transferred to HA may function as HC donors in subsequent transfer reactions" and "a dynamic shuffling of the HCs occur in vivo." The deep research confirms "ITIH2 binds and stabilizes hyaluronan in the ECM, often via TSG-6-mediated transfer." This is a well-supported, specific molecular function annotation. Supporting Evidence: PMID:20463016 The heavy chain (HC) subunits of the bikunin proteins are covalently attached to a single chondroitin sulfate (CS) chain originating from bikunin and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2 file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 binds and stabilizes hyaluronan in the ECM, often via TSG-6-mediated transfer PMID:39149600 HCs have been found to function as structural proteins that can directly cross-link HA that is secreted file:human/ITIH2/ITIH2-deep-research-falcon.md ITIH2's primary molecular function is best summarized as: Extracellular structural modification of hyaluronan (HA) through the provision of HC2, which can become covalently attached to HA to form HC·HA (SHAP–HA) complexes that stabilize and organize HA-rich extracellular matrices
GO:0031012 extracellular matrix	HDA PMID:28327460 Comprehensive proteomic characterization of stem cell-derive...	ACCEPT	Summary: This HDA annotation is based on high-throughput detection in extracellular matrix preparations from stem cell-derived matrices. ITIH2 is a bona fide ECM component through its role in stabilizing hyaluronan. Reason: ITIH2 is a well-established component of the extracellular matrix. The deep research confirms "ITIH2 participates in ECM stabilization by covalently linking to hyaluronan, mediated by TSG-6" and describes it as involved in "ECM stabilization." UniProt states ITIH2 may act as "a binding protein between hyaluronan and other matrix protein." The HDA evidence from proteomics studies of ECM is appropriate for this localization, as ITIH2 functions in the ECM compartment through its interactions with hyaluronan and other matrix components. Supporting Evidence: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 participates in ECM stabilization by covalently linking to hyaluronan, mediated by TSG-6 PMID:28327460 Epub 2017 Mar 7. Comprehensive proteomic characterization of stem cell-derived extracellular matrices. PMID:39149600 Through the formation of covalent connections with hyaluronic acid (HA), the inter-α-trypsin inhibitor (IαI) family collaborates to preserve the stability of the extracellular matrix (ECM)
GO:0031012 extracellular matrix	HDA PMID:28675934 Characterization of the Extracellular Matrix of Normal and D...	ACCEPT	Summary: This HDA annotation is based on proteomic characterization of normal and diseased tissue ECM. This is consistent with ITIH2's role as an ECM-stabilizing protein. Reason: This is the same cellular component as the previous annotation but from a different proteomic study. The evidence supports ITIH2's localization to the extracellular matrix. Multiple independent HDA studies identifying ITIH2 in ECM preparations strengthens confidence in this localization annotation. Supporting Evidence: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 is a secreted plasma protein found in the extracellular space, especially in tissues rich in ECM PMID:28675934 Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.
GO:0031012 extracellular matrix	HDA PMID:25037231 Extracellular matrix signatures of human primary metastatic ...	ACCEPT	Summary: This HDA annotation is from a study of ECM signatures in colon cancer and liver metastases. ITIH2 downregulation in cancer is consistent with its tumor suppressor role. Reason: This annotation from ECM proteomic analysis of cancer tissues is valid. The deep research notes "ITIH2 is downregulated in multiple solid tumors (breast, colon, lung), correlating with loss of tumor suppressor activity and increased invasiveness." The identification of ITIH2 in ECM preparations from cancer tissues, even if at altered levels, confirms its ECM localization and is consistent with its biological role. Supporting Evidence: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 is downregulated in multiple solid tumors (breast, colon, lung), correlating with loss of tumor suppressor activity and increased invasiveness PMID:25037231 Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. PMID:39149600 Strong evidence suggests that genes in the ITIH family may be tumor suppressors because these genes are highly down-regulated in a range of human solid tumors, including lung cancer, breast cancer and colon cancer
GO:0005788 endoplasmic reticulum lumen	TAS Reactome:R-HSA-8952289	REMOVE	Summary: This TAS annotation is based on Reactome pathway annotation for FAM20C phosphorylation of substrates. While ITIH2 is phosphorylated by FAM20C, this kinase is an extracellular kinase, not an ER-localized one. Reason: This annotation appears to be incorrect. The Reactome pathway R-HSA-8952289 describes "FAM20C phosphorylates FAM20C substrates" and notes that "Extracellular serine/threonine protein kinase FAM20C is an extracellular kinase." UniProt confirms ITIH2 is "Phosphorylated by FAM20C in the extracellular medium." ITIH2 is a secreted protein that functions in the extracellular space and is phosphorylated there, not in the ER lumen. While ITIH2 transiently passes through the ER during secretion, annotation to ER lumen does not represent a functionally relevant localization for this mature, secreted protein. Supporting Evidence: Reactome:R-HSA-8952289 Extracellular serine/threonine protein kinase FAM20C is an extracellular kinase that can phosphorylate a broad range of secreted protein file:human/ITIH2/ITIH2-uniprot.txt Phosphorylated by FAM20C in the extracellular medium
GO:0070062 extracellular exosome	HDA PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres...	KEEP AS NON CORE	Summary: This HDA annotation is based on proteomic analysis of exosomes from prostatic secretions. While ITIH2 was detected in these preparations, this likely represents contamination with abundant plasma proteins rather than specific exosomal localization. Reason: ITIH2 is an abundant plasma protein, and its detection in exosome preparations may reflect plasma contamination rather than bona fide exosomal localization. Exosomes are secreted in biological fluids that also contain plasma proteins, making it difficult to distinguish true exosomal components from co-purifying plasma proteins in HDA studies. While ITIH2 may be present in exosomal fractions, this does not represent a core functional localization. The primary and functionally relevant localization of ITIH2 is in plasma and the ECM where it stabilizes hyaluronan. This annotation should be kept but marked as non-core. Supporting Evidence: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 is a secreted plasma protein found in the extracellular space PMID:23533145 2013 Apr 23. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
GO:0072562 blood microparticle	HDA PMID:22516433 Proteomic analysis of microvesicles from plasma of healthy d...	KEEP AS NON CORE	Summary: This HDA annotation is from proteomic analysis of blood microparticles. Similar to exosomal annotations, this likely reflects the presence of abundant plasma proteins rather than specific microparticle association. Reason: ITIH2 is a major plasma protein present at high concentrations in blood. Detection in blood microparticle preparations likely reflects the plasma milieu in which these particles exist rather than specific functional association with microparticles. The title of PMID:22516433 indicates "high individual variability" in the proteomic analysis, suggesting some non-specific associations. While this annotation may be technically correct, it does not represent a core functional localization for ITIH2, whose primary functions are in plasma and ECM. Supporting Evidence: file:human/ITIH2/ITIH2-uniprot.txt Plasma [tissue specificity] PMID:22516433 Epub 2012 Apr 10. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
GO:0070062 extracellular exosome	HDA PMID:20458337 MHC class II-associated proteins in B-cell exosomes and pote...	KEEP AS NON CORE	Summary: This is another HDA annotation for extracellular exosome from a different study (B-cell exosomes). The same concerns about plasma protein contamination apply. Reason: This is the same issue as the previous exosomal annotation but from a different study. PMID:20458337 analyzed "MHC class II-associated proteins in B-cell exosomes." While ITIH2 was detected, as an abundant plasma protein, it likely represents contamination rather than specific functional association with B-cell exosomes. The core functions of ITIH2 relate to ECM stabilization and hyaluronan binding, not exosome biology. Keep as non-core. Supporting Evidence: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md ITIH2 is a secreted plasma protein found in the extracellular space PMID:20458337 2010 May 11. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
GO:0005576 extracellular region	NAS PMID:14718574 The human plasma proteome: a nonredundant list developed by ...	ACCEPT	Summary: This NAS annotation is based on the plasma proteome study. This is a duplicate of the earlier GO:0005576 annotation but with experimental evidence (NAS) rather than IEA. Reason: This annotation is correct and supported by direct experimental evidence. PMID:14718574 identified ITIH2 in "The human plasma proteome" through multiple methodologies. This provides stronger evidence than the IEA annotation for the same term. ITIH2 is indeed located in the extracellular region (plasma and ECM). While this term is broad, it is accurate and well-supported by this proteomics study. Supporting Evidence: PMID:14718574 The human plasma proteome: a nonredundant list developed by combination of four separate sources
GO:0004866 endopeptidase inhibitor activity	TAS PMID:2476436 Analysis of inter-alpha-trypsin inhibitor and a novel trypsi...	REMOVE	Summary: This TAS annotation is from a traceable author statement in PMID:2476436. However, like the IEA annotations for protease inhibitor activity, this incorrectly attributes the inhibitory activity of the complex to the ITIH2 heavy chain. Reason: While PMID:2476436 is a foundational paper on inter-alpha-inhibitor structure, the endopeptidase inhibitor activity resides in bikunin, not ITIH2. The paper explicitly states "Analysis of the proteins, the separated chains, and proteolytic derivatives thereof revealed that each protein contained a single, identical, trypsin-inhibitory chain of 30,000 Da" (bikunin) and "Inter-alpha-trypsin inhibitor contains noninhibitory heavy chains of 65,000 and 70,000 Da." This annotation conflates the complex's activity with ITIH2's individual function. ITIH2 is a structural component that does not possess intrinsic endopeptidase inhibitor activity. Supporting Evidence: PMID:2476436 Inter-alpha-trypsin inhibitor contains noninhibitory heavy chains of 65,000 and 70,000 Da, whereas pre-alpha-trypsin inhibitor contains a heavy chain of 90,000 Da

Core Functions

Transferring to and binding hyaluronan via TSG-6-mediated transesterification reactions to stabilize the extracellular matrix as a heavy chain component of the inter-alpha-inhibitor complex

Molecular Function:

hyaluronic acid binding

Directly Involved In:

hyaluronan metabolic process

Cellular Locations:

extracellular matrix extracellular region

Substrates:

hyaluronic acid

Supporting Evidence:

PMID:20463016
The heavy chain (HC) subunits of the bikunin proteins are covalently attached to a single chondroitin sulfate (CS) chain originating from bikunin and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2
PMID:7504674
A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor
file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
ITIH2 participates in ECM stabilization by covalently linking to hyaluronan, mediated by TSG-6
file:human/ITIH2/ITIH2-uniprot.txt
May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes
PMID:39149600
TSG-6 is essential for the interaction with HA because it facilitates two following ester exchange reactions: it binds HC1 or HC2 of IαI family covalently and then moves them to the HA fraction in this complex, where the heavy chain conjugates and releases free TSG-6
file:human/ITIH2/ITIH2-deep-research-falcon.md
ITIH2's primary molecular function is best summarized as: Extracellular structural modification of hyaluronan (HA) through the provision of HC2, which can become covalently attached to HA to form HC·HA (SHAP–HA) complexes that stabilize and organize HA-rich extracellular matrices

References

file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md

Deep research on ITIH2 gene function and biology

file:human/ITIH2/ITIH2-deep-research-falcon.md

Falcon (Edison Scientific Literature) deep research on ITIH2 — synthesizes 2024 reviews on the inter-alpha-trypsin inhibitor heavy chain H2, including the TSG-6-catalyzed covalent transesterification of HC2 onto hyaluronan, the resulting HC·HA (SHAP-HA) structural complexes that stabilize HA-rich extracellular matrix, proteolytic editing of HC·HA by ADAMTS5/MMP7, and disease associations (tumor suppression in solid cancers, follicular fluid biomarkers for embryo quality, late-onset preeclampsia)

file:human/ITIH2/ITIH2-uniprot.txt

UniProt entry for ITIH2

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms.

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods.

PMID:14718574

The human plasma proteome: a nonredundant list developed by combination of four separate sources.

PMID:16873769

TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

PMID:20458337

MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.

PMID:20463016

The TSG-6/HC2-mediated transfer is a dynamic process shuffling heavy chains between glycosaminoglycans.

PMID:22516433

Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.

PMID:23533145

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

PMID:2476436

Analysis of inter-alpha-trypsin inhibitor and a novel trypsin inhibitor, pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain stoichiometry and assembly by glycan.

PMID:7504674

A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor.

PMID:25037231

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.

PMID:28327460

Comprehensive proteomic characterization of stem cell-derived extracellular matrices.

PMID:28675934

Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.

PMID:38791985

Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.

PMID:39149600

The function of the inter-alpha-trypsin inhibitors in the development of disease.

Reactome:R-HSA-8952289

FAM20C phosphorylates FAM20C substrates

Deep Research

Falcon

(ITIH2-deep-research-falcon.md)

this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 26 citations 2 artifacts 2026-05-29T19:01:44.399146

Edison artifact artifact-00 (text/markdown)

## Context ID: pqac-00000018 Figure 2 presents a schematic model illustrating the process of cumulus expansion and the formation of the hyaluronan-rich extracel (image/png)

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Human ITIH2 (UniProt P19823) — functional annotation and current understanding

0) Target verification (correct gene/protein)

The literature synthesized here concerns human inter-α-trypsin inhibitor heavy chain H2 (ITIH2; “HC2”), a secreted plasma heavy chain in the inter-α-inhibitor (IαI) family that participates in covalent heavy-chain transfer to hyaluronan (HA) (also described as SHAP/HC•HA). This matches the UniProt identity given (P19823; Homo sapiens; ITIH family) and is distinct from other HA-binding receptors (e.g., CD44) or unrelated genes with similar acronyms. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7)

1) Key concepts and definitions (current understanding)

1.1 Inter-α-trypsin inhibitor (IαI) family and ITIH2’s role

The IαI family comprises serum-derived complexes built from a light chain (bikunin) plus heavy chains (including HC2/ITIH2). Hepatocytes are a major source of these complexes, which circulate at high concentration. (zhang2024thefunctionof pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)

A key conceptual point is that protease inhibition is primarily attributed to bikunin, while the best-characterized function of heavy chains (including ITIH2/HC2) is structural, namely covalent modification of HA in extracellular matrices; this is why heavy chains are termed “serum-derived hyaluronan-associated proteins (SHAP)” once transferred onto HA. (xu2024hyaluronicacidinteracting pages 6-7)

1.2 HC•HA / SHAP–HA complexes

HC•HA refers to hyaluronan covalently modified with IαI heavy chains, forming HA/protein assemblies that can change HA’s organization and biological effects in the extracellular matrix. HC•HA formation is widely used to explain how HA acquires distinct architectures and functions in physiology and disease. (day2024hyaluronan‐proteininteractionslilliput pages 15-15, xu2024hyaluronicacidinteracting pages 6-7)

1.3 TSG-6 (TNFAIP6) as a catalyst for heavy-chain transfer

The TNF-stimulated gene-6 protein (TSG-6 / TNFAIP6) is central to HC transfer. It catalyzes heavy-chain movement from IαI-like donors onto HA via sequential ester-exchange (transesterification) reactions, involving temporary covalent heavy-chain–TSG-6 intermediates. (zhang2024thefunctionof pages 1-2, day2024hyaluronan‐proteininteractionslilliput pages 15-15)

2) Molecular function and biochemical mechanism (ITIH2-centric)

2.1 Primary molecular function

Across current authoritative sources, ITIH2’s primary molecular function is best summarized as:
- Extracellular structural modification of hyaluronan (HA) through the provision of HC2, which can become covalently attached to HA to form HC•HA (SHAP–HA) complexes that stabilize and organize HA-rich extracellular matrices. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7, nagyova2024uniquehyaluronanstructure pages 2-4)

This is not an enzyme in the classical “substrate → product” sense; rather, ITIH2 contributes a reactive heavy chain that becomes part of the HA polymer’s covalent decoration.

2.2 Mechanistic steps of HC2 transfer to HA (TSG-6-dependent)

Mechanistic descriptions converge on the following model:
1. IαI-like complexes deliver HC2 (and other HCs) to tissues. (zhang2024thefunctionof pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)
2. TSG-6 forms a covalent intermediate with HC2 (HC2•TSG-6) and then transfers HC2 onto HA, releasing free TSG-6. (zhang2024thefunctionof pages 1-2, day2024hyaluronan‐proteininteractionslilliput pages 15-15)
3. This transfer requires a sufficiently long HA acceptor; a key mechanistic parameter reported is that the minimum even-length HA oligomer that can accept an HC is an octasaccharide (HA8), with certain chemical modifications enabling shorter oligomers to serve as substrates. (day2024hyaluronan‐proteininteractionslilliput pages 15-15)

In the cancer/HA-interaction literature, this is additionally described as a transesterification reaction in which TSG-6 and HA form a stable complex and heavy-chain transfer is promoted with assistance by calcium ions. (xu2024hyaluronicacidinteracting pages 6-7)

2.3 Post-synthetic “editing” and remodeling of HC•HA containing HC2

A notable recent mechanistic refinement is that, after HC•HA forms, heavy chains can be re-distributed (“shuffled”) between HA molecules or transferred back onto the bikunin chondroitin sulfate (CS) chain to form higher-molecular-weight IαI species; this implies dynamic extracellular remodeling rather than a single terminal state. (day2024hyaluronan‐proteininteractionslilliput pages 16-17)

Moreover, in arthritis synovial fluid, HC2 can be proteolytically cleaved from HC•HA by proteases (e.g., ADAMTS5 and MMP7), suggesting that proteolytic ‘editing’ can alter the composition—and potentially the bioactivity—of HC•HA matrices. (day2024hyaluronan‐proteininteractionslilliput pages 16-17)

3) Subcellular/extracellular localization and tissue context

3.1 Where ITIH2 is produced and where it acts

The functional model is strongly extracellular:
- Production: IαI family proteins are synthesized/assembled in liver (hepatocyte-centric framing) and secreted into blood/plasma. (zhang2024thefunctionof pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)
- Site of action: Following recruitment to tissues, only the heavy chains (including HC2) are transferred onto locally synthesized HA in the extracellular matrix to generate HC•HA structures. (zhang2024thefunctionof pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)

These descriptions align with ITIH2 being a secreted precursor protein whose main function is executed outside cells in HA-rich ECM.

3.2 Physiological matrix contexts highlighted in recent literature

Reproductive biology (cumulus expansion/ovulation): A particularly well-defined context is the expanded oocyte–cumulus extracellular matrix (ECM) in preovulatory follicles, where serum-derived heavy chains covalently bind HA and stabilize the HA-rich matrix essential for ovulation and fertilization. (nagyova2024uniquehyaluronanstructure pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)

A schematic figure in a 2024 review illustrates the in vivo path: liver synthesis → circulation → follicle → covalent HC–HA formation, and also shows that serum is required in vitro to retain/stabilize HA matrices around oocyte–cumulus complexes. (nagyova2024uniquehyaluronanstructure media fa68c96c)

4) Recent developments and latest research (prioritizing 2023–2024)

4.1 2024: Mechanistic consolidation of HC transfer chemistry and substrate constraints

Day (2024) consolidates newer mechanistic details for TSG-6-mediated HC transfer, including the HC•TSG-6 covalent intermediates and the HA octasaccharide minimum acceptor size for HC transfer, plus discussion of how chemical modification can change acceptor competence. (day2024hyaluronan‐proteininteractionslilliput pages 15-15)

4.2 2024: Disease-focused synthesis for ITIH family and ITIH2

A 2024 Frontiers in Medicine review compiles disease associations for ITIH2 and related ITIH family members, emphasizing ECM stabilization mechanisms and presenting several quantitative biomarker-performance statistics (see Section 6). While much of this is secondary synthesis, it is a useful map of clinical directions and hypotheses being emphasized in 2024. (zhang2024thefunctionof pages 1-2, zhang2024thefunctionof pages 5-6)

4.3 2024: Human follicular-fluid proteomics linking ITIH2 to embryo quality

In a 2024 Reproductive Sciences study, human follicular fluid proteomics (IVF/ICSI context) reported ITIH2 among proteins upregulated in follicles associated with higher-quality day-3 embryos, consistent with a role for ITIH2/HC2 in follicular/cumulus matrix biology and oocyte developmental competence. (ji2024aproteomicanalysis pages 3-6)

5) Pathways and systems-level roles (authoritative interpretation)

5.1 Core pathway: HA organization via HC transfer (TSG-6 axis)

The most defensible “pathway” annotation for ITIH2 is the TSG-6–mediated HA remodeling axis:
- ITIH2 supplies HC2
- TSG-6 catalyzes HC transfer onto HA
- resulting HC•HA matrices alter ECM mechanics and HA-dependent receptor functions.

This is explicitly linked to ECM stability and to HA structural regulation in multiple 2024 reviews. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7, day2024hyaluronan‐proteininteractionslilliput pages 15-15)

5.2 Cancer-relevant signaling hypotheses (secondary/interpretive)

The 2024 disease-focused review reports that ITIH2 is associated with phenotypes such as increased intercellular adhesion, suppressed proliferation, and reduced glioblastoma invasion, and proposes decreased PI3K/AKT signaling activity as a mechanism in that context. This should be treated as a disease-context hypothesis rather than ITIH2’s primary biochemical function. (zhang2024thefunctionof pages 3-5, zhang2024thefunctionof pages 5-6)

6) Current applications and real-world implementations (biomarkers; translational uses)

6.1 Reproductive medicine (biomarker discovery in IVF)

Human follicular-fluid proteomics has been used to develop candidate biomarkers of embryo quality beyond morphology. In the 2024 Ji et al. study:
- 22 follicular fluid samples (hqFF n=11 vs nhqFF n=11)
- 558 proteins identified
- 50 differentially expressed proteins (32 upregulated, 18 downregulated)
- DEPs called at >1.20-fold or <0.67-fold with P<0.05 thresholds
ITIH2 is reported among the proteins upregulated in the high-quality embryo group, suggesting potential use in noninvasive biomarker strategies. (ji2024aproteomicanalysis pages 3-6)

6.2 Obstetrics (preeclampsia phenotyping)

In a maternal plasma proteomics study of early- vs late-onset preeclampsia, ITIH2 was confirmed perturbed only in late-onset preeclampsia (LOPE) in validation, providing a concrete example of ITIH2 being used in proteomic signatures to distinguish disease phenotypes. (chen2022maternalplasmaproteome pages 5-6)

In related platelet/plasma multi-omics work, ITIH2 (with ITIH3) is discussed as a likely mediator/marker of thrombo-inflammation in gestational hypertension and preeclampsia—another real-world setting where ITIH2 enters biomarker panels and mechanistic hypotheses in pregnancy complications. (almeida2022proteomicsandmetabolomics pages 1-2)

6.3 Oncology/infectious disease/other diagnostic signatures (review-synthesized)

The 2024 review by Zhang et al. compiles multiple proposed diagnostic applications for ITIH2 in diverse diseases, including ROC/AUC-based performance in some settings. This indicates broad exploration of ITIH2 as a circulating protein biomarker, but also highlights a limitation: different diseases may perturb the same heavy chain, constraining specificity. (zhang2024thefunctionof pages 5-6)

7) Relevant statistics and quantitative data (recent studies)

Key quantitative findings available in the retrieved sources include:
- Serum concentration of IαI family proteins: ~0.15–0.5 mg/mL in blood (reported in a 2024 review), consistent with their role as abundant plasma-derived ECM modifiers. (zhang2024thefunctionof pages 1-2)
- Mechanistic constraint on HA acceptor size: minimum even-length HA oligomer to accept HC transfer is octasaccharide. (day2024hyaluronan‐proteininteractionslilliput pages 15-15)
- Follicular fluid proteomics (2024): n=22 FF samples (11 vs 11); 558 proteins; 50 DEPs; thresholds as above; ITIH2 upregulated in the high-quality embryo group. (ji2024aproteomicanalysis pages 3-6)
- Late-onset preeclampsia validation (2022): ITIH2 validation logFC 0.37228745, p=0.005, with discovery table FDR 0.03. (chen2022maternalplasmaproteome pages 5-6)
- Review-compiled diagnostic performance examples (2024): pancreatic cancer diagnostic biomarker AUC 0.947; osteoarticular tuberculosis AUC 0.7167 (95% CI 0.5846–0.8487). (zhang2024thefunctionof pages 5-6)

8) Expert opinions and analysis (authoritative source perspectives)

8.1 What authoritative reviews agree on

Across mechanistic and disease-oriented 2024 reviews, there is strong agreement that:
- ITIH2’s heavy chain participates in covalent HA modification (SHAP/HC•HA formation) via TSG-6 catalysis, and this is the best-characterized molecular function of heavy chains. (xu2024hyaluronicacidinteracting pages 6-7, day2024hyaluronan‐proteininteractionslilliput pages 15-15)
- The biological impact of ITIH2 is therefore best understood through ECM physics/architecture and HA receptor biology, rather than through a classical enzymatic active site or transporter substrate profile. (zhang2024thefunctionof pages 1-2, day2024hyaluronan‐proteininteractionslilliput pages 15-15)

8.2 Key uncertainties and open questions

Recent reviews also emphasize that important in vivo questions remain open:
- Whether HC “shuffling” among HA chains is beneficial or deleterious in inflammatory disease progression is not yet clearly tested in vivo models (e.g., arthritis). (day2024hyaluronan‐proteininteractionslilliput pages 16-17)
- Proteolytic “editing” (e.g., ADAMTS5/MMP7 cleavage of HC2 from HC•HA) can change bioactivity, but the net physiological consequences require further clarification. (day2024hyaluronan‐proteininteractionslilliput pages 16-17)

9) Disease associations and external evidence (knowledge-graph view)

OpenTargets lists multiple disease associations for ITIH2 (e.g., non-alcoholic fatty liver disease, neurodegenerative disease, type 2 diabetes mellitus), indicating that genetic and/or functional evidence has been aggregated across diverse indications; these associations should be interpreted as hypothesis-generating rather than a direct statement of ITIH2’s biochemical mechanism. (OpenTargets Search: -ITIH2)

10) Evidence summary table and key figure

The following table compiles mechanism, localization, and quantitative human findings from recent sources:

Aspect	Key points	Quantitative/statistical details	Primary source (include DOI URL + year)
ITIH2/HC2 identity in the IαI family	Human ITIH2 encodes heavy chain 2 (HC2) of the inter-α-trypsin inhibitor (IαI) family; hepatocyte-derived serum complexes contain bikunin plus heavy chains, and HC1/HC2 are the major heavy chains in classical human IαI. HC2 is linked to bikunin through a chondroitin sulfate chain and is not the protease-inhibitory moiety; that activity resides in bikunin. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7)	IαI complexes are ~225 kDa and circulate in blood at ~0.15–0.5 mg/mL; serum concentration also reported as ~0.5 mg/mL in reproductive/ECM literature. (zhang2024thefunctionof pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4)	Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224; Xu et al., 2024, https://doi.org/10.3390/cancers16101907; Nagyova et al., 2024, https://doi.org/10.2478/enr-2024-0020
HC2 transfer to hyaluronan via TSG-6	HC2 is transferred from IαI to hyaluronan (HA) by TSG-6/TNFAIP6 through sequential ester-exchange/transesterification reactions involving a covalent HC2•TSG-6 intermediate, generating HC•HA (SHAP-HA) complexes that stabilize HA-rich extracellular matrices. Calcium ions assist this process; TSG-6 can act as the catalytic transferase. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7, day2024hyaluronan‐proteininteractionslilliput pages 15-15)	Minimum HA acceptor length for HC transfer is an octasaccharide; chemically modified HA tetra- and hexa-saccharides can also become substrates in some settings. Expected HC1 and HC2 transfer can be approximately equal depending on which HC•TSG-6 intermediate forms. (day2024hyaluronan‐proteininteractionslilliput pages 15-15)	Day, 2024, https://doi.org/10.1002/pgr2.70007; Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224; Xu et al., 2024, https://doi.org/10.3390/cancers16101907
Localization	ITIH2/HC2 is produced mainly in liver, secreted into plasma as part of IαI, then functions extracellularly after transfer onto locally synthesized HA in tissues/ECM. HC2-containing HC•HA complexes are found in extracellular matrices and can be remodeled post-synthetically by proteolysis. (zhang2024thefunctionof pages 1-2, day2024hyaluronan‐proteininteractionslilliput pages 16-17, nagyova2024uniquehyaluronanstructure pages 2-4)	Blood concentration of IαI family proteins: ~0.15–0.5 mg/mL or ~0.5 mg/mL depending on source/review context. HC2 can be proteolytically removed from HC•HA by ADAMTS5 and MMP7 in arthritis synovial fluid. (zhang2024thefunctionof pages 1-2, day2024hyaluronan‐proteininteractionslilliput pages 16-17, nagyova2024uniquehyaluronanstructure pages 2-4)	Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224; Day, 2024, https://doi.org/10.1002/pgr2.70007; Nagyova et al., 2024, https://doi.org/10.2478/enr-2024-0020
ECM structural role	The best-established function of HC2 is structural: covalent HA modification/crosslinking that stabilizes extracellular matrix architecture, affects HA organization, and can modulate cell adhesion/rolling through effects on CD44-containing matrices. (zhang2024thefunctionof pages 1-2, xu2024hyaluronicacidinteracting pages 6-7, day2024hyaluronan‐proteininteractionslilliput pages 15-15)	No direct catalytic turnover number reported in provided sources; mechanistic quantitative detail available is HA octasaccharide minimum substrate size for HC transfer. (day2024hyaluronan‐proteininteractionslilliput pages 15-15)	Day, 2024, https://doi.org/10.1002/pgr2.70007; Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224; Xu et al., 2024, https://doi.org/10.3390/cancers16101907
Physiological context: ovulation/cumulus expansion	In preovulatory follicles, serum-derived HC2 (with HC1/HC3) becomes covalently attached to cumulus-cell HA, helping build the expanded HA-rich oocyte-cumulus extracellular matrix required for ovulation and fertilization. This matrix also involves TNFAIP6/TSG-6, PTX3, versican, and bikunin. (nagyova2024uniquehyaluronanstructure pages 1-2, nagyova2024uniquehyaluronanstructure pages 2-4, nagyova2024uniquehyaluronanstructure media fa68c96c)	Mouse OCC proteomics produced >24,000 mass spectra and identified 711 proteins; ITIH1, ITIH2, ITIH3, PTX3, TNFAIP6, VCAN, and VTN were among the seven especially abundant expansion-related components. At least 34 bikunin target genes were identified in earlier reproductive studies. (nagyova2024uniquehyaluronanstructure pages 2-4)	Nagyova et al., 2024, https://doi.org/10.2478/enr-2024-0020
Figure-supported mechanism	A recent schematic depicts liver synthesis of IαI, circulation to the follicle, and covalent binding of heavy chains to HA in vivo; the in vitro panel shows serum dependence for retaining/stabilizing the HA matrix around the oocyte-cumulus complex. (nagyova2024uniquehyaluronanstructure media fa68c96c)	Qualitative schematic support; no additional numeric statistic in figure extraction. (nagyova2024uniquehyaluronanstructure media fa68c96c)	Nagyova et al., 2024, https://doi.org/10.2478/enr-2024-0020
Human reproductive biomarker/proteomics finding (2024)	In human follicular fluid from IVF/ICSI patients, ITIH2 was among proteins upregulated in follicles yielding higher-quality day-3 embryos, consistent with a role in HA-rich cumulus/follicular matrix biology. (ji2024aproteomicanalysis pages 3-6)	Study analyzed 22 follicular-fluid samples from 19 women; 558 proteins identified; 50 differentially expressed proteins total (32 upregulated, 18 downregulated) using >1.20-fold or <0.67-fold and P<0.05 thresholds. ITIH2 was reported as upregulated in the high-quality embryo group. (ji2024aproteomicanalysis pages 3-6)	Ji et al., 2024, https://doi.org/10.1007/s43032-023-01293-x
Human pregnancy biomarker finding (LOPE)	Maternal plasma proteomics found ITIH2 perturbed specifically in late-onset preeclampsia (LOPE), not early-onset preeclampsia in validation, supporting disease-context-specific regulation. (chen2022maternalplasmaproteome pages 5-6)	Validation logFC for ITIH2 in LOPE vs healthy pregnancy: 0.37228745; FDR in discovery table: 0.03; validation p=0.005. (chen2022maternalplasmaproteome pages 5-6)	Chen et al., 2022, https://doi.org/10.1038/s41598-022-20658-x
Human thrombo-inflammation association	Plasma/platelet multi-omics in gestational hypertension and preeclampsia implicated ITIH2 (with ITIH3) as likely mediators of thrombo-inflammation rather than simple background markers. (almeida2022proteomicsandmetabolomics pages 1-2)	Clinical context statistic: preeclampsia complicates up to 8% of pregnancies; diagnostic thresholds noted as >140/90 mmHg and proteinuria ≥300 mg/24 h. Specific ITIH2 fold-change was not given in the excerpt. (almeida2022proteomicsandmetabolomics pages 1-2)	de Almeida et al., 2022, https://doi.org/10.3390/cells11081256
Disease/biomarker review summary for ITIH2	Review-level synthesis reports multiple human disease associations for ITIH2, including reduced serum levels in pediatric multiple sclerosis, pancreatic cancer diagnosis, diabetic retinopathy-associated vitreous changes, and osteoarticular tuberculosis diagnosis; these are associations, not proof of primary molecular function. (zhang2024thefunctionof pages 5-6)	Pancreatic cancer vs chronic pancreatitis AUC=0.947; osteoarticular tuberculosis AUC=0.7167 (95% CI 0.5846–0.8487). Breast-cancer estrogen receptor association reported as p=0.001 elsewhere in the review. (zhang2024thefunctionof pages 5-6, zhang2024thefunctionof pages 3-5)	Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224
Cancer-related functional interpretation	ITIH2 is described as increasing intercellular adhesion, suppressing proliferation, and limiting glioblastoma invasion, potentially via reduced PI3K/AKT signaling; this aligns with an ECM-stabilizing/tumor-suppressive interpretation rather than enzyme activity. (zhang2024thefunctionof pages 5-6, zhang2024thefunctionof pages 3-5)	Review cites breast-cancer correlation with estrogen receptor expression at p=0.001; no direct effect size for PI3K/AKT reduction provided in excerpt. (zhang2024thefunctionof pages 5-6, zhang2024thefunctionof pages 3-5)	Zhang et al., 2024, https://doi.org/10.3389/fmed.2024.1432224

Table: This table summarizes the core molecular role of human ITIH2/HC2 in the inter-alpha-inhibitor system, its extracellular localization and HA-transfer mechanism, and recent clinical/proteomic findings with quantitative details where available. It is useful as a compact evidence map linking biochemical function to physiological and disease contexts.

A 2024 figure summarizing the liver-to-follicle route and serum dependence of HA–HC matrix formation in cumulus expansion is available here (schematic): (nagyova2024uniquehyaluronanstructure media fa68c96c)

11) Key references (with URLs and publication dates)

Day AJ. Hyaluronan-protein interactions: Lilliput revisited. Proteoglycan Research (Oct 2024). https://doi.org/10.1002/pgr2.70007 (day2024hyaluronan‐proteininteractionslilliput pages 15-15, day2024hyaluronan‐proteininteractionslilliput pages 16-17)
Zhang X-f et al. The function of the inter-alpha-trypsin inhibitors in the development of disease. Frontiers in Medicine (Published 01 Aug 2024). https://doi.org/10.3389/fmed.2024.1432224 (zhang2024thefunctionof pages 1-2, zhang2024thefunctionof pages 5-6, zhang2024thefunctionof pages 3-5)
Xu Y et al. Hyaluronic Acid Interacting Molecules Mediated Crosstalk… Cancers (May 2024). https://doi.org/10.3390/cancers16101907 (xu2024hyaluronicacidinteracting pages 6-7)
Nagyova E et al. Unique hyaluronan structure of expanded oocyte-cumulus extracellular matrix in ovarian follicles. Endocrine Regulations (Jan 2024). https://doi.org/10.2478/enr-2024-0020 (nagyova2024uniquehyaluronanstructure pages 2-4, nagyova2024uniquehyaluronanstructure media fa68c96c)
Ji J et al. A Proteomic Analysis of Human Follicular Fluid… Reproductive Sciences (Aug 2024; online 2023). https://doi.org/10.1007/s43032-023-01293-x (ji2024aproteomicanalysis pages 3-6)
Chen H et al. Maternal plasma proteome profiling… preeclampsia. Scientific Reports (Nov 2022). https://doi.org/10.1038/s41598-022-20658-x (chen2022maternalplasmaproteome pages 5-6)
de Almeida LGN et al. Proteomics and Metabolomics Profiling… preeclampsia. Cells (07 Apr 2022). https://doi.org/10.3390/cells11081256 (almeida2022proteomicsandmetabolomics pages 1-2)

References

(zhang2024thefunctionof pages 1-2): Xin-feng Zhang, Xiao-li Zhang, Li Guo, Yun-ping Bai, Yan Tian, and Hua-you Luo. The function of the inter-alpha-trypsin inhibitors in the development of disease. Frontiers in Medicine, Aug 2024. URL: https://doi.org/10.3389/fmed.2024.1432224, doi:10.3389/fmed.2024.1432224. This article has 37 citations.
(xu2024hyaluronicacidinteracting pages 6-7): Yali Xu, Johannes Benedikt, and Lin Ye. Hyaluronic acid interacting molecules mediated crosstalk between cancer cells and microenvironment from primary tumour to distant metastasis. Cancers, 16:1907, May 2024. URL: https://doi.org/10.3390/cancers16101907, doi:10.3390/cancers16101907. This article has 26 citations.
(nagyova2024uniquehyaluronanstructure pages 2-4): Eva Nagyova, Alzbeta Bujnakova Mlynarcikova, Lucie Nemcova, and Sona Scsukova. Unique hyaluronan structure of expanded oocyte-cumulus extracellular matrix in ovarian follicles. Endocrine Regulations, 58:174-180, Jan 2024. URL: https://doi.org/10.2478/enr-2024-0020, doi:10.2478/enr-2024-0020. This article has 2 citations.
(day2024hyaluronan‐proteininteractionslilliput pages 15-15): Anthony J. Day. Hyaluronan‐protein interactions: lilliput revisited. Proteoglycan Research, Oct 2024. URL: https://doi.org/10.1002/pgr2.70007, doi:10.1002/pgr2.70007. This article has 15 citations.
(day2024hyaluronan‐proteininteractionslilliput pages 16-17): Anthony J. Day. Hyaluronan‐protein interactions: lilliput revisited. Proteoglycan Research, Oct 2024. URL: https://doi.org/10.1002/pgr2.70007, doi:10.1002/pgr2.70007. This article has 15 citations.
(nagyova2024uniquehyaluronanstructure pages 1-2): Eva Nagyova, Alzbeta Bujnakova Mlynarcikova, Lucie Nemcova, and Sona Scsukova. Unique hyaluronan structure of expanded oocyte-cumulus extracellular matrix in ovarian follicles. Endocrine Regulations, 58:174-180, Jan 2024. URL: https://doi.org/10.2478/enr-2024-0020, doi:10.2478/enr-2024-0020. This article has 2 citations.
(nagyova2024uniquehyaluronanstructure media fa68c96c): Eva Nagyova, Alzbeta Bujnakova Mlynarcikova, Lucie Nemcova, and Sona Scsukova. Unique hyaluronan structure of expanded oocyte-cumulus extracellular matrix in ovarian follicles. Endocrine Regulations, 58:174-180, Jan 2024. URL: https://doi.org/10.2478/enr-2024-0020, doi:10.2478/enr-2024-0020. This article has 2 citations.
(zhang2024thefunctionof pages 5-6): Xin-feng Zhang, Xiao-li Zhang, Li Guo, Yun-ping Bai, Yan Tian, and Hua-you Luo. The function of the inter-alpha-trypsin inhibitors in the development of disease. Frontiers in Medicine, Aug 2024. URL: https://doi.org/10.3389/fmed.2024.1432224, doi:10.3389/fmed.2024.1432224. This article has 37 citations.
(ji2024aproteomicanalysis pages 3-6): Jingjuan Ji, Xinyi Zhu, Yan Zhang, Lijun Shui, Shun Bai, Lingli Huang, Haoyu Wang, Shiwei Fan, Zelin Zhang, Li-hua Luo, and Bo Xu. A proteomic analysis of human follicular fluid: proteomic profile associated with embryo quality. Reproductive sciences, 31:199-211, Aug 2024. URL: https://doi.org/10.1007/s43032-023-01293-x, doi:10.1007/s43032-023-01293-x. This article has 4 citations and is from a peer-reviewed journal.
(zhang2024thefunctionof pages 3-5): Xin-feng Zhang, Xiao-li Zhang, Li Guo, Yun-ping Bai, Yan Tian, and Hua-you Luo. The function of the inter-alpha-trypsin inhibitors in the development of disease. Frontiers in Medicine, Aug 2024. URL: https://doi.org/10.3389/fmed.2024.1432224, doi:10.3389/fmed.2024.1432224. This article has 37 citations.
(chen2022maternalplasmaproteome pages 5-6): Hao Chen, Ingrid Aneman, Valentina Nikolic, Natasa Karadzov Orlic, Zeljko Mikovic, Milan Stefanovic, Zoran Cakic, Hristina Jovanovic, Stephanie E. L. Town, Matthew P. Padula, and Lana McClements. Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia. Scientific Reports, Nov 2022. URL: https://doi.org/10.1038/s41598-022-20658-x, doi:10.1038/s41598-022-20658-x. This article has 40 citations and is from a peer-reviewed journal.
(almeida2022proteomicsandmetabolomics pages 1-2): Luiz Gustavo N. de Almeida, Daniel Young, Lorraine Chow, Joshua Nicholas, Adrienne Lee, Man-Chiu Poon, Antoine Dufour, and Ejaife O. Agbani. Proteomics and metabolomics profiling of platelets and plasma mediators of thrombo-inflammation in gestational hypertension and preeclampsia. Cells, 11:1256, Apr 2022. URL: https://doi.org/10.3390/cells11081256, doi:10.3390/cells11081256. This article has 56 citations.
(OpenTargets Search: -ITIH2): Open Targets Query (-ITIH2, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

Artifacts

Edison artifact artifact-00

Citations

xu2024hyaluronicacidinteracting pages 6-7
ji2024aproteomicanalysis pages 3-6
chen2022maternalplasmaproteome pages 5-6
almeida2022proteomicsandmetabolomics pages 1-2
zhang2024thefunctionof pages 5-6
zhang2024thefunctionof pages 1-2
nagyova2024uniquehyaluronanstructure pages 2-4
nagyova2024uniquehyaluronanstructure pages 1-2
zhang2024thefunctionof pages 3-5
https://doi.org/10.3389/fmed.2024.1432224;
https://doi.org/10.3390/cancers16101907;
https://doi.org/10.2478/enr-2024-0020
https://doi.org/10.1002/pgr2.70007;
https://doi.org/10.3390/cancers16101907
https://doi.org/10.1007/s43032-023-01293-x
https://doi.org/10.1038/s41598-022-20658-x
https://doi.org/10.3390/cells11081256
https://doi.org/10.3389/fmed.2024.1432224
https://doi.org/10.1002/pgr2.70007
https://doi.org/10.3389/fmed.2024.1432224,
https://doi.org/10.3390/cancers16101907,
https://doi.org/10.2478/enr-2024-0020,
https://doi.org/10.1002/pgr2.70007,
https://doi.org/10.1007/s43032-023-01293-x,
https://doi.org/10.1038/s41598-022-20658-x,
https://doi.org/10.3390/cells11081256,

Perplexity

(ITIH2-deep-research-perplexity-lite.md)

1. Key Concepts and Definitions Perplexity sonar-pro 10 citations 2025-11-15T18:33:51.603503

The ITIH2 gene encodes the inter-alpha-trypsin inhibitor heavy chain 2, a protein primarily involved in extracellular matrix (ECM) stabilization, with roles in inflammation, tumor suppression, and disease processes[1][5][6].

1. Key Concepts and Definitions

Molecular Function:
ITIH2 acts as a serine-type endopeptidase inhibitor and binds to hyaluronan, a major ECM component, helping stabilize the matrix and regulate cell migration and tissue integrity[1][6][3]. It is also involved in endopeptidase inhibitor activity[1][9].
Biological Processes:
ITIH2 participates in:
ECM stabilization by covalently linking to hyaluronan, mediated by TSG-6[5][10].
Regulation of inflammation: ITIH2 is downregulated during acute inflammation, acting as a negative acute phase protein[5].
Tumor suppression: ITIH2 is frequently downregulated in solid tumors (breast, colon, lung), suggesting a role in inhibiting tumor growth and metastasis[2][5].
Cell migration and tissue remodeling: ITIH2 is upregulated during wound healing and involved in angiogenesis[5].
Response to exogenous stressors: ITIH2 is a hub gene in hepatotoxicity models, indicating a role in cellular stress responses[8].
Cellular Localization:
ITIH2 is a secreted plasma protein found in the extracellular space, especially in tissues rich in ECM such as the liver, kidney, and various brain regions[6][7][9]. It is detected in urine, especially in disease states like SLE[4].

2. Protein Domains

Gla Domain:
ITIH2 contains a Gla (gamma-carboxyglutamic acid) domain, which requires vitamin K-dependent post-translational modification and is involved in calcium binding[3].
Heavy Chain Domain:
The heavy chain domain enables covalent linkage to hyaluronan and interaction with other ECM proteins[5][10].

3. Known Interactions

Hyaluronan:
ITIH2 binds and stabilizes hyaluronan in the ECM, often via TSG-6-mediated transfer[5][10].
TSG-6:
TSG-6 catalyzes the transfer of ITIH2 heavy chains to hyaluronan, forming HC-HA complexes crucial for ECM integrity and inflammation[5].
Other Matrix Proteins:
ITIH2 may interact with cell surface proteins and other ECM components, influencing cell adhesion and migration[6].
Protein-Protein Interactions:
ITIH2 is identified as a hub protein in several interaction networks, especially in stress and toxicity responses[8].

4. Disease Associations

Cancer:
ITIH2 is downregulated in multiple solid tumors (breast, colon, lung), correlating with loss of tumor suppressor activity and increased invasiveness[2][5]. Its expression is strongly associated with estrogen receptor status in breast cancer[2][5].
Systemic Lupus Erythematosus (SLE):
Urinary ITIH2 levels correlate with SLE activity and renal damage, suggesting a role as a biomarker for lupus nephritis[4].
Thrombophilia Due to HRG Deficiency and Skeletal Tuberculosis:
These are listed as disease associations, though the mechanistic link is less well defined[1].
Psychiatric Disorders:
Genetic studies suggest ITIH2 may share risk factors with schizophrenia and depression, though mechanisms remain under investigation[5].
CNS Tumors:
ITIH2 is expressed in low-grade CNS cancers and normal brain tissue but absent in highly invasive glioblastomas, indicating a possible anti-invasive function[5].

5. Recent Developments and Latest Research (2023–2024)

Tumor Suppression:
Recent studies reinforce ITIH2’s role as a tumor suppressor, with strong evidence of downregulation in solid tumors and its involvement in ECM stabilization to inhibit tumor growth[5].
Inflammation and Acute Phase Response:
ITIH2 is now recognized as a negative acute phase protein, downregulated during inflammation, with contrasting regulation compared to other ITIH family members[5].
SLE Biomarker:
2023–2024 research highlights ITIH2 as a promising urinary biomarker for SLE activity and kidney involvement[4].
Cellular Stress Response:
ITIH2’s role as a hub gene in hepatotoxicity models suggests broader involvement in cellular responses to toxicants[8].

6. Current Applications and Real-World Implementations

Cancer Diagnostics:
ITIH2 expression profiling is used in breast cancer tissue arrays to correlate with estrogen receptor status and tumor grade[2][5].
SLE Monitoring:
Urinary ITIH2 measurement is being explored as a non-invasive marker for lupus nephritis activity[4].
Toxicology:
ITIH2 is studied as a hub gene in models of hepatotoxicity, potentially aiding in the assessment of drug-induced liver injury[8].

7. Expert Opinions and Analysis

Tumor Suppressor Role:
Experts increasingly view ITIH2 and related ITIH family members as critical ECM stabilizers and tumor suppressors, with loss of expression linked to increased malignancy and invasiveness[2][5].
Inflammation Modulation:
ITIH2’s dual role in inflammation (negative acute phase protein) and tissue repair is seen as central to its biological significance[5].
Biomarker Potential:
The correlation of ITIH2 with disease activity in SLE and cancer supports its utility as a biomarker in clinical diagnostics[4][5].

8. Relevant Statistics and Data

Breast Cancer:
Loss of ITIH2 expression was confirmed in 70% of breast cancer cases (n=50), with strong correlation to estrogen receptor expression (p < 0.001)[2].
SLE:
ITIH2 and ECM1 levels in urine show significant correlation with disease activity and renal damage in SLE patients[4].

URLs and Publication Dates

GeneCards ITIH2 summary (accessed 2024)
Frontiers in Medicine review (published 2024)
Wiley SLE biomarker study (published 2023)
PMC cancer study (published 2008, cited for foundational data)
UniProt ITIH2 entry (accessed 2024)
Ma'ayan Lab ITIH2 interactions (accessed 2024)

Summary:
ITIH2 is a secreted ECM protein with serine protease inhibitor activity, crucial for matrix stabilization, inflammation modulation, and tumor suppression. It contains a Gla domain, interacts with hyaluronan via TSG-6, and is downregulated in several cancers and inflammatory diseases. Recent research highlights its biomarker potential in SLE and its broader role in cellular stress responses.

Citations

https://www.genecards.org/cgi-bin/carddisp.pl?gene=ITIH2
https://pmc.ncbi.nlm.nih.gov/articles/PMC2268946/
https://en.wikipedia.org/wiki/ITIH2
https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.24622
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1432224/full
https://www.uniprot.org/uniprotkb/P19823/entry
https://www.proteinatlas.org/ENSG00000151655-ITIH2
https://maayanlab.cloud/Harmonizome/gene/ITIH2
https://geneglobe.qiagen.com/us/knowledge/gene/ENSG00000151655
https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=3698

📄 View Raw YAML

id: P19823
gene_symbol: ITIH2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: Inter-alpha-trypsin inhibitor heavy chain H2 is a secreted plasma
  protein that is a component of the inter-alpha-inhibitor (IαI) protease
  inhibitor complex. ITIH2 acts as a carrier and regulatory protein for
  hyaluronan in the extracellular matrix, participating in ECM stabilization
  through TSG-6-mediated transfer of heavy chains to hyaluronan. The protein
  contains VIT and VWFA domains, is linked to bikunin via chondroitin sulfate,
  and is phosphorylated by FAM20C in the extracellular space.
existing_annotations:
- term:
    id: GO:0004867
    label: serine-type endopeptidase inhibitor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This IEA annotation is based on InterPro domain mapping and
      UniProtKB keyword assignment. While ITIH2 is part of the
      inter-alpha-inhibitor complex, the actual serine protease inhibitor
      activity resides in the bikunin subunit, not in the ITIH2 heavy chain
      itself.
    action: REMOVE
    reason: ITIH2 (the heavy chain H2) does not possess intrinsic serine-type
      endopeptidase inhibitor activity. The inhibitory activity of the
      inter-alpha-inhibitor complex comes from the bikunin light chain, not from
      the heavy chains. As stated in PMID:2476436, "each protein contained a
      single, identical, trypsin-inhibitory chain of 30,000 Da" referring to
      bikunin, while "Inter-alpha-trypsin inhibitor contains noninhibitory heavy
      chains of 65,000 and 70,000 Da." ITIH2 is one of these noninhibitory heavy
      chains. The deep research confirms "ITIH2 acts as a serine-type
      endopeptidase inhibitor" is misleading - it's the bikunin component that
      has this activity.
    supported_by:
    - reference_id: PMID:2476436
      supporting_text: "Analysis of the proteins, the separated chains, and proteolytic
        derivatives thereof revealed that each protein contained a single, identical,
        trypsin-inhibitory chain of 30,000 Da. Inter-alpha-trypsin inhibitor contains
        noninhibitory heavy chains of 65,000 and 70,000 Da"
    - reference_id: file:human/ITIH2/ITIH2-deep-research-falcon.md
      supporting_text: "protease inhibition is primarily attributed to bikunin, while
        the best-characterized function of heavy chains (including ITIH2/HC2) is structural,
        namely covalent modification of HA in extracellular matrices"
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: This IEA annotation is based on UniProtKB subcellular location
      vocabulary mapping. ITIH2 is indeed a secreted protein found in plasma and
      extracellular fluids. However, this term is very broad and less
      informative than more specific cellular component annotations available.
    action: ACCEPT
    reason: While this annotation is correct, it is quite general. ITIH2 is
      secreted into plasma and the extracellular space as confirmed by UniProt
      ("Secreted") and deep research showing it is a "secreted plasma protein
      found in the extracellular space." The annotation is supported by
      experimental evidence (PMID:14718574) which identified ITIH2 in the human
      plasma proteome. This term is acceptable as a broad localization
      statement, though more specific terms like "extracellular matrix" provide
      better functional context.
    supported_by:
    - reference_id: PMID:14718574
      supporting_text: "The human plasma proteome: a nonredundant list developed by
        combination of four separate sources"
- term:
    id: GO:0030212
    label: hyaluronan metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: This IEA annotation is based on InterPro domain mapping. ITIH2
      plays a crucial role in hyaluronan biology through TSG-6-mediated transfer
      of heavy chains to hyaluronan, stabilizing the ECM and regulating
      hyaluronan localization and interactions.
    action: ACCEPT
    reason: This annotation accurately captures a core function of ITIH2. The
      protein is directly involved in hyaluronan metabolic processes through its
      interactions with hyaluronan. PMID:20463016 demonstrates that "TSG-6/HC2
      transfer HCs from bikunin proteins to HA" and shows "a dynamic shuffling
      of the HCs occur in vivo" between glycosaminoglycans including hyaluronan.
      The deep research confirms ITIH2 "binds and stabilizes hyaluronan in the
      ECM" and is "covalently linking to hyaluronan, mediated by TSG-6." UniProt
      states ITIH2 may act as "a binding protein between hyaluronan and other
      matrix protein...to regulate the localization, synthesis and degradation
      of hyaluronan."
    supported_by:
    - reference_id: PMID:20463016
      supporting_text: "The heavy chain (HC) subunits of the bikunin proteins are
        covalently attached to a single chondroitin sulfate (CS) chain originating
        from bikunin and can be transferred to different hyaluronan (HA) molecules
        by TSG-6/HC2"
    - reference_id: file:human/ITIH2/ITIH2-uniprot.txt
      supporting_text: "May act as a carrier of hyaluronan in serum or as a binding
        protein between hyaluronan and other matrix protein, including those on cell
        surfaces in tissues to regulate the localization, synthesis and degradation
        of hyaluronan"
    - reference_id: PMID:39149600
      supporting_text: "TSG-6 is essential for the interaction with HA because it
        facilitates two following ester exchange reactions: it binds HC1 or HC2 of
        IαI family covalently and then moves them to the HA fraction in this complex,
        where the heavy chain conjugates and releases free TSG-6"
- term:
    id: GO:0030414
    label: peptidase inhibitor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This IEA annotation is based on UniProtKB keyword mapping. Like
      GO:0004867, this annotation incorrectly attributes the protease inhibitor
      activity of the inter-alpha-inhibitor complex to the ITIH2 heavy chain,
      when it actually resides in the bikunin subunit.
    action: REMOVE
    reason: ITIH2 itself does not have peptidase inhibitor activity. This is the
      same fundamental issue as GO:0004867. The heavy chains (including
      ITIH2/HC2) are structural components that are linked to bikunin via
      chondroitin sulfate, but they do not possess enzymatic inhibitor activity.
      PMID:2476436 clearly identifies bikunin as "the trypsin-inhibitory chain"
      while describing ITIH2 and other heavy chains as "noninhibitory." The
      annotation conflates the complex's activity with ITIH2's individual
      molecular function.
    supported_by:
    - reference_id: PMID:2476436
      supporting_text: "Inter-alpha-trypsin inhibitor contains noninhibitory heavy
        chains of 65,000 and 70,000 Da"
    - reference_id: file:human/ITIH2/ITIH2-deep-research-falcon.md
      supporting_text: "This is not an enzyme in the classical \"substrate → product\"
        sense; rather, ITIH2 contributes a reactive heavy chain that becomes part
        of the HA polymer's covalent decoration"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16873769
  review:
    summary: This IPI annotation is based on experimental evidence showing ITIH2
      interaction with bikunin in the context of TSG-6-mediated complex
      formation. While technically correct, the generic "protein binding" term
      is uninformative and should be replaced with more specific molecular
      function terms.
    action: MODIFY
    reason: PMID:16873769 demonstrates that TSG-6 interacts with heavy chains
      from inter-alpha-inhibitor, stating "TSG-6 forms covalent complexes with
      heavy chains (HCs) from inter-alpha-inhibitor and pre-alpha-inhibitor and
      associates noncovalently with their common bikunin chain." While this
      confirms protein-protein interaction, the term "protein binding" is too
      vague per curation guidelines. ITIH2's role is better captured by more
      specific terms describing its function in hyaluronan binding and ECM
      organization rather than generic protein binding.
    proposed_replacement_terms:
    - id: GO:0005540
      label: hyaluronic acid binding
    supported_by:
    - reference_id: PMID:16873769
      supporting_text: "TSG-6 (the protein product of TNF-stimulated gene-6), an inflammation-associated
        protein, forms covalent complexes with heavy chains (HCs) from inter-alpha-inhibitor
        and pre-alpha-inhibitor and associates noncovalently with their common bikunin
        chain"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20463016
  review:
    summary: This IPI annotation is based on experimental evidence showing ITIH2
      interaction with TSG-6 and involvement in the dynamic transfer of heavy
      chains between glycosaminoglycans. Like the previous protein binding
      annotation, this is too generic.
    action: MODIFY
    reason: PMID:20463016 demonstrates extensive protein-protein interactions in
      the context of TSG-6/HC2-mediated transfer, showing "TSG-6 and HC2
      transfer HCs from bikunin proteins to HA in a reaction that involves two
      sequential transesterifications." While protein binding is occurring, this
      generic term does not capture the specific molecular function. The paper
      demonstrates hyaluronan binding activity and dynamic interactions with
      glycosaminoglycans, which are better represented by GO:0005540 (hyaluronic
      acid binding).
    proposed_replacement_terms:
    - id: GO:0005540
      label: hyaluronic acid binding
    supported_by:
    - reference_id: PMID:20463016
      supporting_text: "In concert, TSG-6 and HC2 transfer HCs from bikunin proteins
        to HA in a reaction that involves two sequential transesterifications"
- term:
    id: GO:0005540
    label: hyaluronic acid binding
  evidence_type: IDA
  original_reference_id: PMID:20463016
  review:
    summary: This IDA annotation is based on direct experimental evidence
      demonstrating ITIH2's ability to bind hyaluronan through TSG-6-mediated
      transfer reactions. This represents a core molecular function of ITIH2.
    action: ACCEPT
    reason: This annotation accurately captures a core molecular function of
      ITIH2. PMID:20463016 directly demonstrates that "heavy chain (HC) subunits
      of the bikunin proteins...can be transferred to different hyaluronan (HA)
      molecules by TSG-6/HC2" and shows "HC·HA complex" formation. The paper
      demonstrates reversible binding, showing "HCs transferred to HA may
      function as HC donors in subsequent transfer reactions" and "a dynamic
      shuffling of the HCs occur in vivo." The deep research confirms "ITIH2
      binds and stabilizes hyaluronan in the ECM, often via TSG-6-mediated
      transfer." This is a well-supported, specific molecular function
      annotation.
    supported_by:
    - reference_id: PMID:20463016
      supporting_text: "The heavy chain (HC) subunits of the bikunin proteins are
        covalently attached to a single chondroitin sulfate (CS) chain originating
        from bikunin and can be transferred to different hyaluronan (HA) molecules
        by TSG-6/HC2"
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 binds and stabilizes hyaluronan in the ECM, often via
        TSG-6-mediated transfer"
    - reference_id: PMID:39149600
      supporting_text: "HCs have been found to function as structural proteins that
        can directly cross-link HA that is secreted"
    - reference_id: file:human/ITIH2/ITIH2-deep-research-falcon.md
      supporting_text: "ITIH2's primary molecular function is best summarized as: Extracellular
        structural modification of hyaluronan (HA) through the provision of HC2, which
        can become covalently attached to HA to form HC·HA (SHAP–HA) complexes that
        stabilize and organize HA-rich extracellular matrices"
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: HDA
  original_reference_id: PMID:28327460
  review:
    summary: This HDA annotation is based on high-throughput detection in
      extracellular matrix preparations from stem cell-derived matrices. ITIH2
      is a bona fide ECM component through its role in stabilizing hyaluronan.
    action: ACCEPT
    reason: ITIH2 is a well-established component of the extracellular matrix.
      The deep research confirms "ITIH2 participates in ECM stabilization by
      covalently linking to hyaluronan, mediated by TSG-6" and describes it as
      involved in "ECM stabilization." UniProt states ITIH2 may act as "a
      binding protein between hyaluronan and other matrix protein." The HDA
      evidence from proteomics studies of ECM is appropriate for this
      localization, as ITIH2 functions in the ECM compartment through its
      interactions with hyaluronan and other matrix components.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 participates in ECM stabilization by covalently linking
        to hyaluronan, mediated by TSG-6"
    - reference_id: PMID:28327460
      supporting_text: Epub 2017 Mar 7. Comprehensive proteomic characterization
        of stem cell-derived extracellular matrices.
    - reference_id: PMID:39149600
      supporting_text: "Through the formation of covalent connections with hyaluronic
        acid (HA), the inter-α-trypsin inhibitor (IαI) family collaborates to preserve
        the stability of the extracellular matrix (ECM)"
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: HDA
  original_reference_id: PMID:28675934
  review:
    summary: This HDA annotation is based on proteomic characterization of
      normal and diseased tissue ECM. This is consistent with ITIH2's role as an
      ECM-stabilizing protein.
    action: ACCEPT
    reason: This is the same cellular component as the previous annotation but
      from a different proteomic study. The evidence supports ITIH2's
      localization to the extracellular matrix. Multiple independent HDA studies
      identifying ITIH2 in ECM preparations strengthens confidence in this
      localization annotation.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 is a secreted plasma protein found in the extracellular
        space, especially in tissues rich in ECM"
    - reference_id: PMID:28675934
      supporting_text: Characterization of the Extracellular Matrix of Normal
        and Diseased Tissues Using Proteomics.
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: HDA
  original_reference_id: PMID:25037231
  review:
    summary: This HDA annotation is from a study of ECM signatures in colon
      cancer and liver metastases. ITIH2 downregulation in cancer is consistent
      with its tumor suppressor role.
    action: ACCEPT
    reason: This annotation from ECM proteomic analysis of cancer tissues is
      valid. The deep research notes "ITIH2 is downregulated in multiple solid
      tumors (breast, colon, lung), correlating with loss of tumor suppressor
      activity and increased invasiveness." The identification of ITIH2 in ECM
      preparations from cancer tissues, even if at altered levels, confirms its
      ECM localization and is consistent with its biological role.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 is downregulated in multiple solid tumors (breast, colon,
        lung), correlating with loss of tumor suppressor activity and increased invasiveness"
    - reference_id: PMID:25037231
      supporting_text: Extracellular matrix signatures of human primary
        metastatic colon cancers and their metastases to liver.
    - reference_id: PMID:39149600
      supporting_text: "Strong evidence suggests that genes in the ITIH family may
        be tumor suppressors because these genes are highly down-regulated in a range
        of human solid tumors, including lung cancer, breast cancer and colon cancer"
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952289
  review:
    summary: This TAS annotation is based on Reactome pathway annotation for
      FAM20C phosphorylation of substrates. While ITIH2 is phosphorylated by
      FAM20C, this kinase is an extracellular kinase, not an ER-localized one.
    action: REMOVE
    reason: This annotation appears to be incorrect. The Reactome pathway
      R-HSA-8952289 describes "FAM20C phosphorylates FAM20C substrates" and
      notes that "Extracellular serine/threonine protein kinase FAM20C is an
      extracellular kinase." UniProt confirms ITIH2 is "Phosphorylated by FAM20C
      in the extracellular medium." ITIH2 is a secreted protein that functions
      in the extracellular space and is phosphorylated there, not in the ER
      lumen. While ITIH2 transiently passes through the ER during secretion,
      annotation to ER lumen does not represent a functionally relevant
      localization for this mature, secreted protein.
    supported_by:
    - reference_id: Reactome:R-HSA-8952289
      supporting_text: "Extracellular serine/threonine protein kinase FAM20C is an
        extracellular kinase that can phosphorylate a broad range of secreted protein"
    - reference_id: file:human/ITIH2/ITIH2-uniprot.txt
      supporting_text: "Phosphorylated by FAM20C in the extracellular medium"
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  review:
    summary: This HDA annotation is based on proteomic analysis of exosomes from
      prostatic secretions. While ITIH2 was detected in these preparations, this
      likely represents contamination with abundant plasma proteins rather than
      specific exosomal localization.
    action: KEEP_AS_NON_CORE
    reason: ITIH2 is an abundant plasma protein, and its detection in exosome
      preparations may reflect plasma contamination rather than bona fide
      exosomal localization. Exosomes are secreted in biological fluids that
      also contain plasma proteins, making it difficult to distinguish true
      exosomal components from co-purifying plasma proteins in HDA studies.
      While ITIH2 may be present in exosomal fractions, this does not represent
      a core functional localization. The primary and functionally relevant
      localization of ITIH2 is in plasma and the ECM where it stabilizes
      hyaluronan. This annotation should be kept but marked as non-core.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 is a secreted plasma protein found in the extracellular
        space"
    - reference_id: PMID:23533145
      supporting_text: 2013 Apr 23. In-depth proteomic analyses of exosomes
        isolated from expressed prostatic secretions in urine.
- term:
    id: GO:0072562
    label: blood microparticle
  evidence_type: HDA
  original_reference_id: PMID:22516433
  review:
    summary: This HDA annotation is from proteomic analysis of blood
      microparticles. Similar to exosomal annotations, this likely reflects the
      presence of abundant plasma proteins rather than specific microparticle
      association.
    action: KEEP_AS_NON_CORE
    reason: ITIH2 is a major plasma protein present at high concentrations in
      blood. Detection in blood microparticle preparations likely reflects the
      plasma milieu in which these particles exist rather than specific
      functional association with microparticles. The title of PMID:22516433
      indicates "high individual variability" in the proteomic analysis,
      suggesting some non-specific associations. While this annotation may be
      technically correct, it does not represent a core functional localization
      for ITIH2, whose primary functions are in plasma and ECM.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-uniprot.txt
      supporting_text: "Plasma [tissue specificity]"
    - reference_id: PMID:22516433
      supporting_text: Epub 2012 Apr 10. Proteomic analysis of microvesicles
        from plasma of healthy donors reveals high individual variability.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:20458337
  review:
    summary: This is another HDA annotation for extracellular exosome from a
      different study (B-cell exosomes). The same concerns about plasma protein
      contamination apply.
    action: KEEP_AS_NON_CORE
    reason: This is the same issue as the previous exosomal annotation but from
      a different study. PMID:20458337 analyzed "MHC class II-associated
      proteins in B-cell exosomes." While ITIH2 was detected, as an abundant
      plasma protein, it likely represents contamination rather than specific
      functional association with B-cell exosomes. The core functions of ITIH2
      relate to ECM stabilization and hyaluronan binding, not exosome biology.
      Keep as non-core.
    supported_by:
    - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
      supporting_text: "ITIH2 is a secreted plasma protein found in the extracellular
        space"
    - reference_id: PMID:20458337
      supporting_text: 2010 May 11. MHC class II-associated proteins in B-cell
        exosomes and potential functional implications for exosome biogenesis.
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: NAS
  original_reference_id: PMID:14718574
  review:
    summary: This NAS annotation is based on the plasma proteome study. This is
      a duplicate of the earlier GO:0005576 annotation but with experimental
      evidence (NAS) rather than IEA.
    action: ACCEPT
    reason: This annotation is correct and supported by direct experimental
      evidence. PMID:14718574 identified ITIH2 in "The human plasma proteome"
      through multiple methodologies. This provides stronger evidence than the
      IEA annotation for the same term. ITIH2 is indeed located in the
      extracellular region (plasma and ECM). While this term is broad, it is
      accurate and well-supported by this proteomics study.
    supported_by:
    - reference_id: PMID:14718574
      supporting_text: "The human plasma proteome: a nonredundant list developed by
        combination of four separate sources"
- term:
    id: GO:0004866
    label: endopeptidase inhibitor activity
  evidence_type: TAS
  original_reference_id: PMID:2476436
  review:
    summary: This TAS annotation is from a traceable author statement in
      PMID:2476436. However, like the IEA annotations for protease inhibitor
      activity, this incorrectly attributes the inhibitory activity of the
      complex to the ITIH2 heavy chain.
    action: REMOVE
    reason: While PMID:2476436 is a foundational paper on inter-alpha-inhibitor
      structure, the endopeptidase inhibitor activity resides in bikunin, not
      ITIH2. The paper explicitly states "Analysis of the proteins, the
      separated chains, and proteolytic derivatives thereof revealed that each
      protein contained a single, identical, trypsin-inhibitory chain of 30,000
      Da" (bikunin) and "Inter-alpha-trypsin inhibitor contains noninhibitory
      heavy chains of 65,000 and 70,000 Da." This annotation conflates the
      complex's activity with ITIH2's individual function. ITIH2 is a structural
      component that does not possess intrinsic endopeptidase inhibitor
      activity.
    supported_by:
    - reference_id: PMID:2476436
      supporting_text: "Inter-alpha-trypsin inhibitor contains noninhibitory heavy
        chains of 65,000 and 70,000 Da, whereas pre-alpha-trypsin inhibitor contains
        a heavy chain of 90,000 Da"
core_functions:
- description: Transferring to and binding hyaluronan via TSG-6-mediated
    transesterification reactions to stabilize the extracellular matrix as a
    heavy chain component of the inter-alpha-inhibitor complex
  molecular_function:
    id: GO:0005540
    label: hyaluronic acid binding
  directly_involved_in:
  - id: GO:0030212
    label: hyaluronan metabolic process
  locations:
  - id: GO:0031012
    label: extracellular matrix
  - id: GO:0005576
    label: extracellular region
  anatomical_locations:
  - id: UBERON:0001088
    label: urine
  - id: UBERON:0001969
    label: blood plasma
  substrates:
  - id: CHEBI:16336
    label: hyaluronic acid
  supported_by:
  - reference_id: PMID:20463016
    supporting_text: "The heavy chain (HC) subunits of the bikunin proteins are covalently
      attached to a single chondroitin sulfate (CS) chain originating from bikunin
      and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2"
  - reference_id: PMID:7504674
    supporting_text: "A serum-derived hyaluronan-associated protein (SHAP) is the
      heavy chain of the inter alpha-trypsin inhibitor"
  - reference_id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
    supporting_text: "ITIH2 participates in ECM stabilization by covalently linking
      to hyaluronan, mediated by TSG-6"
  - reference_id: file:human/ITIH2/ITIH2-uniprot.txt
    supporting_text: "May act as a carrier of hyaluronan in serum or as a binding
      protein between hyaluronan and other matrix protein, including those on cell
      surfaces in tissues to regulate the localization, synthesis and degradation
      of hyaluronan which are essential to cells undergoing biological processes"
  - reference_id: PMID:39149600
    supporting_text: "TSG-6 is essential for the interaction with HA because it facilitates
      two following ester exchange reactions: it binds HC1 or HC2 of IαI family covalently
      and then moves them to the HA fraction in this complex, where the heavy chain
      conjugates and releases free TSG-6"
  - reference_id: file:human/ITIH2/ITIH2-deep-research-falcon.md
    supporting_text: "ITIH2's primary molecular function is best summarized as: Extracellular
      structural modification of hyaluronan (HA) through the provision of HC2, which
      can become covalently attached to HA to form HC·HA (SHAP–HA) complexes that
      stabilize and organize HA-rich extracellular matrices"
references:
- id: file:human/ITIH2/ITIH2-deep-research-perplexity-lite.md
  title: Deep research on ITIH2 gene function and biology
  findings: []
- id: file:human/ITIH2/ITIH2-deep-research-falcon.md
  title: Falcon (Edison Scientific Literature) deep research on ITIH2 — synthesizes
    2024 reviews on the inter-alpha-trypsin inhibitor heavy chain H2, including the
    TSG-6-catalyzed covalent transesterification of HC2 onto hyaluronan, the resulting
    HC·HA (SHAP-HA) structural complexes that stabilize HA-rich extracellular matrix,
    proteolytic editing of HC·HA by ADAMTS5/MMP7, and disease associations (tumor
    suppression in solid cancers, follicular fluid biomarkers for embryo quality,
    late-onset preeclampsia)
  findings: []
- id: file:human/ITIH2/ITIH2-uniprot.txt
  title: UniProt entry for ITIH2
  findings: []
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with
    GO terms.
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
    Location vocabulary mapping, accompanied by conservative changes to GO terms
    applied by UniProt.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:14718574
  title: 'The human plasma proteome: a nonredundant list developed by combination
    of four separate sources.'
  findings: []
- id: PMID:16873769
  title: TSG-6 potentiates the antitissue kallikrein activity of
    inter-alpha-inhibitor through bikunin release.
  findings: []
- id: PMID:20458337
  title: MHC class II-associated proteins in B-cell exosomes and potential
    functional implications for exosome biogenesis.
  findings: []
- id: PMID:20463016
  title: The TSG-6/HC2-mediated transfer is a dynamic process shuffling heavy
    chains between glycosaminoglycans.
  findings: []
- id: PMID:22516433
  title: Proteomic analysis of microvesicles from plasma of healthy donors
    reveals high individual variability.
  findings: []
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed
    prostatic secretions in urine.
  findings: []
- id: PMID:2476436
  title: Analysis of inter-alpha-trypsin inhibitor and a novel trypsin
    inhibitor, pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain
    stoichiometry and assembly by glycan.
  findings: []
- id: PMID:7504674
  title: A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain
    of the inter alpha-trypsin inhibitor.
  findings: []
- id: PMID:25037231
  title: Extracellular matrix signatures of human primary metastatic colon
    cancers and their metastases to liver.
  findings: []
- id: PMID:28327460
  title: Comprehensive proteomic characterization of stem cell-derived
    extracellular matrices.
  findings: []
- id: PMID:28675934
  title: Characterization of the Extracellular Matrix of Normal and Diseased
    Tissues Using Proteomics.
  findings: []
- id: PMID:38791985
  title: Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer
    Cells and Microenvironment from Primary Tumour to Distant Metastasis.
  findings: []
- id: PMID:39149600
  title: The function of the inter-alpha-trypsin inhibitors in the development of
    disease.
  findings: []
- id: Reactome:R-HSA-8952289
  title: FAM20C phosphorylates FAM20C substrates
  findings: []

Gene Description

Existing Annotations Review

Core Functions

Transferring to and binding hyaluronan via TSG-6-mediated transesterification reactions to stabilize the extracellular matrix as a heavy chain component of the inter-alpha-inhibitor complex

References

Deep Research

Falcon

Research report: Human ITIH2 (UniProt P19823) — functional annotation and current understanding

0) Target verification (correct gene/protein)

1) Key concepts and definitions (current understanding)

1.1 Inter-α-trypsin inhibitor (IαI) family and ITIH2’s role

1.2 HC•HA / SHAP–HA complexes

1.3 TSG-6 (TNFAIP6) as a catalyst for heavy-chain transfer

2) Molecular function and biochemical mechanism (ITIH2-centric)

2.1 Primary molecular function

2.2 Mechanistic steps of HC2 transfer to HA (TSG-6-dependent)

2.3 Post-synthetic “editing” and remodeling of HC•HA containing HC2

3) Subcellular/extracellular localization and tissue context

3.1 Where ITIH2 is produced and where it acts

3.2 Physiological matrix contexts highlighted in recent literature

4) Recent developments and latest research (prioritizing 2023–2024)

4.1 2024: Mechanistic consolidation of HC transfer chemistry and substrate constraints

4.2 2024: Disease-focused synthesis for ITIH family and ITIH2

4.3 2024: Human follicular-fluid proteomics linking ITIH2 to embryo quality

5) Pathways and systems-level roles (authoritative interpretation)

5.1 Core pathway: HA organization via HC transfer (TSG-6 axis)

5.2 Cancer-relevant signaling hypotheses (secondary/interpretive)

6) Current applications and real-world implementations (biomarkers; translational uses)

6.1 Reproductive medicine (biomarker discovery in IVF)

6.2 Obstetrics (preeclampsia phenotyping)

6.3 Oncology/infectious disease/other diagnostic signatures (review-synthesized)

7) Relevant statistics and quantitative data (recent studies)

8) Expert opinions and analysis (authoritative source perspectives)

8.1 What authoritative reviews agree on

8.2 Key uncertainties and open questions

9) Disease associations and external evidence (knowledge-graph view)

10) Evidence summary table and key figure

11) Key references (with URLs and publication dates)

Artifacts

Citations

Perplexity

1. Key Concepts and Definitions

2. Protein Domains

3. Known Interactions

4. Disease Associations

5. Recent Developments and Latest Research (2023–2024)

6. Current Applications and Real-World Implementations

7. Expert Opinions and Analysis

8. Relevant Statistics and Data

URLs and Publication Dates

Citations

📄 View Raw YAML